Drugs and Devices

FDA approves treatment for hereditary angioedema

The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in people ages 18 years and older. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares